The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2013
Filed:
Dec. 05, 2008
Misun Won, Daejeon, KR;
Kyung-sook Chung, Daejeon, KR;
Young-joo Kim, Daejeon, KR;
Shin-jung Choi, Daejeon, KR;
Young IL Yeom, Daejeon, KR;
Seon-young Kim, Daejeon, KR;
Kyung Bin Song, Daejeon, KR;
Hee Gu Lee, Daejeon, KR;
Eun Young Song, Seoul, KR;
Young Ho Kim, Seoul, KR;
Ho Kyung Chun, Seoul, KR;
Chae-ok Yun, Seoul, KR;
Moon Hee Kim, Seoul, KR;
Kyeong-eun Jung, Anyang-si, KR;
Sun-jung Cho, Gyeongju-si, KR;
Misun Won, Daejeon, KR;
Kyung-Sook Chung, Daejeon, KR;
Young-Joo Kim, Daejeon, KR;
Shin-Jung Choi, Daejeon, KR;
Young Il Yeom, Daejeon, KR;
Seon-Young Kim, Daejeon, KR;
Kyung Bin Song, Daejeon, KR;
Hee Gu Lee, Daejeon, KR;
Eun Young Song, Seoul, KR;
Young Ho Kim, Seoul, KR;
Ho Kyung Chun, Seoul, KR;
Chae-Ok Yun, Seoul, KR;
Moon Hee Kim, Seoul, KR;
Kyeong-Eun Jung, Anyang-si, KR;
Sun-Jung Cho, Gyeongju-si, KR;
Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;
St. Pharm Co., Ltd., Siheung-si, KR;
Abstract
Provided are a composition for diagnosing cancer or screening an anticancer drug comprising an FLJ25416 gene or an antibody directed to a protein expressed from the FLJ25416 gene, a composition for treating cancer comprising an inhibitor of the gene or an inhibitor of the protein expressed from the gene and a pharmaceutically acceptable carrier, and a kit for diagnosing cancer comprising at least one of the FLJ25416 gene and the protein expressed from the FLJ25416 gene. The FLJ25416 gene is expressed at high level in specific cancer cells, and induces an increase in proliferation rate of normal cells. The expression of the gene is suppressed, which results in an inhibitory effect on cancer cell growth. Thus, the FLJ25416 gene can be used as a target gene for diagnosis or treatment of cancer.